Soleus Capital Management, L.P. Xenon Pharmaceuticals Inc. Transaction History

Soleus Capital Management, L.P.

$1.18 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $172,200 - $278,760	6,000 Added 11.54%	58,000 $2.67 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $478,239 - $556,220	-14,000 Reduced 21.21%	52,000 $1.78 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $2.3 Million - $2.87 Million	66,000 New	66,000 $2.54 Million
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $1.94 Million - $2.32 Million	-58,800 Reduced 60.74%	38,000 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $671,222 - $868,076	21,800 Added 29.07%	96,800 $3.49 Million
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $2.92 Million - $4.04 Million	-114,797 Reduced 60.48%	75,000 $2.28 Million
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $4.75 Million - $6.27 Million	-189,200 Reduced 49.92%	189,797 $5.8 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $2.55 Million - $5.78 Million	163,300 Added 75.71%	378,997 $11.8 Million
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $267,480 - $350,100	-18,000 Reduced 7.7%	215,697 $3.3 Million
Q2 2021 Aug 16, 2021	SELL	$16.81 - $20.0 $7.98 Million - $9.49 Million	-474,420 Reduced 67.0%	233,697 $4.35 Million
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $2.05 Million - $3.2 Million	150,000 Added 26.88%	708,117 $12.7 Million
Q4 2020 Feb 16, 2021	BUY	$9.49 - $16.04 $549,024 - $927,962	57,853 Added 11.56%	558,117 $8.58 Million
Q3 2020 Nov 13, 2020	BUY	$10.82 - $13.35 $2.7 Million - $3.33 Million	249,367 Added 99.39%	500,264 $5.54 Million
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $2.43 Million - $3.54 Million	237,669 Added 1796.71%	250,897 $3.15 Million
Q1 2020 May 15, 2020	SELL	$8.08 - $17.57 $1.2 Million - $2.61 Million	-148,372 Reduced 91.81%	13,228 $150,000
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $1.31 Million - $2.37 Million	161,600 New	161,600 $2.12 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

Avoro Capital Advisors LLC New York, NY

5.67M
Shares

$217 Million
3.36% of portfolio
Driehaus Capital Management LLC Chicago, IL

4.6M
Shares

$176 Million
1.77% of portfolio
Wellington Management Group LLP Boston, MA

3.84M
Shares

$147 Million
0.03% of portfolio
Braidwell LP Stamford, CT

2.71M
Shares

$104 Million
3.02% of portfolio
Commodore Capital LP New York, NY

2.7M
Shares

$103 Million
9.03% of portfolio

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account